Anti-factor Xa Monitoring and Activated Charcoal for a Pediatric Patient With Rivaroxaban Overdose

Rivaroxaban, an oral anticoagulant, directly inhibits factor Xa (FXa). A 35-month-old boy was brought to the emergency department 15 minutes after ingesting 200 mg of rivaroxaban (16 mg/kg). Activated charcoal (AC) was administered; the patient was observed with monitoring of plasma anti-FXa levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Carr, Brendan M., Roy, David J., Bangh, Stacey A., Hellmich, Thomas R., Walker, Laura E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075494/
https://www.ncbi.nlm.nih.gov/pubmed/30083644
http://dx.doi.org/10.5811/cpcem.2018.5.38373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075494/
https://www.ncbi.nlm.nih.gov/pubmed/30083644
http://dx.doi.org/10.5811/cpcem.2018.5.38373

Ejemplares similares